DE69840526D1 - Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens - Google Patents
Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agensInfo
- Publication number
- DE69840526D1 DE69840526D1 DE69840526T DE69840526T DE69840526D1 DE 69840526 D1 DE69840526 D1 DE 69840526D1 DE 69840526 T DE69840526 T DE 69840526T DE 69840526 T DE69840526 T DE 69840526T DE 69840526 D1 DE69840526 D1 DE 69840526D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory agent
- nitrogen monoxide
- inhaled nitrogen
- inhaled
- monoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6292697P | 1997-10-21 | 1997-10-21 | |
US08/971,003 US6656452B1 (en) | 1997-10-21 | 1997-11-14 | Use of inhaled NO as anti-inflammatory agent |
PCT/US1998/022044 WO1999020251A1 (en) | 1997-10-21 | 1998-10-19 | Use of inhaled no as anti-inflammatory agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69840526D1 true DE69840526D1 (de) | 2009-03-19 |
Family
ID=26742873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69840526T Expired - Lifetime DE69840526D1 (de) | 1997-10-21 | 1998-10-19 | Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens |
Country Status (13)
Country | Link |
---|---|
US (2) | US6656452B1 (de) |
EP (1) | EP1073416B1 (de) |
JP (1) | JP2003532615A (de) |
AR (1) | AR015973A1 (de) |
AT (1) | ATE421874T1 (de) |
AU (1) | AU751853B2 (de) |
CA (1) | CA2309038C (de) |
CY (1) | CY1110228T1 (de) |
DE (1) | DE69840526D1 (de) |
DK (1) | DK1073416T3 (de) |
ES (1) | ES2319240T3 (de) |
PT (1) | PT1073416E (de) |
WO (1) | WO1999020251A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834506A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosales therapeutisches System zur Anwendung von Sildenafil |
US20030070674A1 (en) * | 2001-10-12 | 2003-04-17 | Bryan Perry | Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
US7086397B2 (en) * | 2002-02-16 | 2006-08-08 | Graham Lindley Spruiell | Patient usable emergency medical kit |
US7091207B2 (en) * | 2002-05-22 | 2006-08-15 | Virginia Commonwealth University | Method of treating myocardial infarction with PDE-5 inhibitors |
CN1668316A (zh) * | 2002-06-12 | 2005-09-14 | 梅瑟·格里斯海姆有限公司 | 含氙的解痉药 |
EP1515753A4 (de) * | 2002-06-21 | 2009-07-15 | Univ Pittsburgh | Pharmazeutische verwendung von stickoxid, heme oxygenase-1 und produkte des heme-abbaus |
SE0300971D0 (sv) * | 2003-04-03 | 2003-04-03 | Aga Ab | Nitric oxide in treatment of inflammation |
CA2536827C (en) * | 2003-07-09 | 2014-09-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
US20050255178A1 (en) * | 2004-02-04 | 2005-11-17 | Bloch Kenneth D | Enhancing the effectiveness of an inhaled therapeutic gas |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
WO2006125123A2 (en) * | 2005-05-19 | 2006-11-23 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
US7829097B2 (en) * | 2006-02-06 | 2010-11-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of HMGB1 for protection against ischemia reperfusion injury |
WO2008063868A2 (en) * | 2006-11-07 | 2008-05-29 | The General Hospital Corporation | Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
WO2008132239A1 (en) | 2007-04-30 | 2008-11-06 | Nnoxe Pharmaceutiques Inc | Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon |
WO2010049423A1 (en) * | 2008-10-27 | 2010-05-06 | Life Sciences Research Partners Vzw | Effects of nitric oxide inhalation on long-term myocardial reperfusion injury |
NO2440239T3 (de) | 2009-06-09 | 2018-02-10 | ||
JP5581500B2 (ja) * | 2010-03-10 | 2014-09-03 | 学校法人北里研究所 | 虚血再灌流障害軽減用治療剤および治療装置 |
EP3360557A3 (de) * | 2010-12-03 | 2018-11-07 | Geno LLC | Stickoxidbehandlungen |
WO2013052548A2 (en) | 2011-10-03 | 2013-04-11 | Nitric Generation Technologies Llc | Apparatus and method for generating nitric oxide in controlled and accurate amounts |
EP2776047A4 (de) | 2011-11-07 | 2015-07-22 | Gen Hospital Corp | Behandlung von erythrozyten |
JP2014141536A (ja) * | 2014-05-16 | 2014-08-07 | Kitasato Institute | 虚血再灌流障害軽減用治療剤および治療装置 |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
WO2023190532A1 (ja) * | 2022-03-29 | 2023-10-05 | 康太郎 木田 | 横紋筋融解症を治療するための医薬組成物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5396882A (en) | 1992-03-11 | 1995-03-14 | The General Hospital Corporation | Generation of nitric oxide from air for medical uses |
US5536241A (en) * | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
DE69133575T2 (de) * | 1990-12-05 | 2008-04-17 | The General Hospital Corp., Boston | Verwendung von NO zur Behandlung der persistenten pulmonaren Hypertonie des Neugeborenen |
US5570683A (en) * | 1990-12-05 | 1996-11-05 | The General Hospital Corporation | Methods and devices for treating pulmonary vasoconstriction and asthma |
US5427797A (en) | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
GB9320978D0 (en) | 1993-10-12 | 1993-12-01 | Higenbottam Timohy W | Nitric oxide treatment |
ES2149338T3 (es) | 1993-11-02 | 2000-11-01 | Us Health | Utilizacion de compuestos que liberan oxido nitrico para la fabricacion de un medicamento destinado al tratamiento de lesiones por reperfusion isquemica. |
US5521191A (en) | 1994-10-17 | 1996-05-28 | Washington University | Method for treatment of arterial stenosis |
US6063407A (en) | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US5823180A (en) | 1995-04-03 | 1998-10-20 | The General Hospital Corporation | Methods for treating pulmonary vasoconstriction and asthma |
US5703073A (en) * | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
US5725492A (en) * | 1996-03-04 | 1998-03-10 | Cormedics Corp | Extracorporeal circulation apparatus and method |
ES2267141T3 (es) | 1996-04-05 | 2007-03-01 | The General Hospital Corporation | Tratamiento de una hemoglobinopatia. |
US6601580B1 (en) | 2000-06-28 | 2003-08-05 | The General Hospital Corporation | Enhancing therapeutic effectiveness of nitric oxide inhalation |
-
1997
- 1997-11-14 US US08/971,003 patent/US6656452B1/en not_active Expired - Fee Related
-
1998
- 1998-10-19 EP EP98953702A patent/EP1073416B1/de not_active Expired - Lifetime
- 1998-10-19 ES ES98953702T patent/ES2319240T3/es not_active Expired - Lifetime
- 1998-10-19 DK DK98953702T patent/DK1073416T3/da active
- 1998-10-19 WO PCT/US1998/022044 patent/WO1999020251A1/en active IP Right Grant
- 1998-10-19 JP JP2000516651A patent/JP2003532615A/ja active Pending
- 1998-10-19 PT PT98953702T patent/PT1073416E/pt unknown
- 1998-10-19 AU AU11012/99A patent/AU751853B2/en not_active Ceased
- 1998-10-19 DE DE69840526T patent/DE69840526D1/de not_active Expired - Lifetime
- 1998-10-19 CA CA002309038A patent/CA2309038C/en not_active Expired - Fee Related
- 1998-10-19 AT AT98953702T patent/ATE421874T1/de active
- 1998-10-20 AR ARP980105231A patent/AR015973A1/es unknown
-
2003
- 2003-10-27 US US10/694,490 patent/US6811768B2/en not_active Expired - Lifetime
-
2009
- 2009-04-13 CY CY20091100436T patent/CY1110228T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999020251A1 (en) | 1999-04-29 |
EP1073416A4 (de) | 2004-07-07 |
US6811768B2 (en) | 2004-11-02 |
AR015973A1 (es) | 2001-05-30 |
ES2319240T3 (es) | 2009-05-05 |
US20040096523A1 (en) | 2004-05-20 |
US6656452B1 (en) | 2003-12-02 |
EP1073416B1 (de) | 2009-01-28 |
PT1073416E (pt) | 2009-03-17 |
CY1110228T1 (el) | 2015-01-14 |
JP2003532615A (ja) | 2003-11-05 |
AU751853B2 (en) | 2002-08-29 |
EP1073416A1 (de) | 2001-02-07 |
CA2309038A1 (en) | 1999-04-29 |
ATE421874T1 (de) | 2009-02-15 |
AU1101299A (en) | 1999-05-10 |
DK1073416T3 (da) | 2009-03-09 |
CA2309038C (en) | 2009-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69840526D1 (de) | Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens | |
ATE202347T1 (de) | Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren | |
DE59803292D1 (de) | Triazolverbindungen und deren verwendung als dopamin-d 3-liganden | |
DE69826662D1 (de) | 4-brom or 4-iod-phenylamino-benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren | |
DE69926154D1 (de) | Pyridin-3-carbonsäurederivate und ihre Verwendung als Zwischenprodukte | |
DE69825288D1 (de) | Prodrugs und konjugate von selenolenthaltenden verbindungen und ihre verwendung | |
ATE231883T1 (de) | Neuartige aminosäurederivate und deren verwendung als thrombininhibitoren | |
ATE186447T1 (de) | Zusammensetzung und verwendung | |
DE69907146D1 (de) | Direkte oxidation von cycloalkanen | |
DE69801878D1 (de) | Verwendung von Oxamatderivaten als Depigmentierungsmittel | |
DE69808266D1 (de) | Herstellung und verwendung von alpha-ketoamid derivate und anordnunge | |
ATE232207T1 (de) | N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten | |
DE69510228T2 (de) | Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel | |
ID17406A (id) | Benda-benda penyerap berpori | |
DE69832902D1 (de) | Oromukosal-zytokin-zusammensetzungen und ihre verwendung | |
NO996545L (no) | Behandling av aluminiumslagg | |
DE69821988D1 (de) | Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva | |
DE59708755D1 (de) | Verwendung von 3-Acylthiohexylestern als Aroma- und Riechstoffe | |
DE69808866D1 (de) | Herstellung von Titanschlacke | |
DE69708500D1 (de) | Sauerstoff-Stahlherstellung | |
DE59809194D1 (de) | 8-Ocimenylester und ihre Verwendung als Riech- und Aromastoffe | |
DE59702428D1 (de) | Verwendung von hydroxycarbonsäureestern als verdickungsmittel | |
DE59605796D1 (de) | Oximether- und acrylsäurederivate und ihre verwendung als fungizide | |
ID18317A (id) | Pembuatan suatu komposisi multi-logam aktif secara katalitik | |
DE69831427D1 (de) | Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |